Third Harmonic Bio Net Income

The latest net income for THRD is $-26M as of March 2025. That compares with $-15M in the prior-year period — down 73.4% year over year. That is below the sector sector average of $130M. Investors often review this figure alongside Third Harmonic Bio's historical trend and sector peers before judging valuation or financial health.

Over the past year, THRD's net income moved from $-15M to $-26M — a 73.4% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Third Harmonic Bio's operating scale or balance-sheet position.

Against its sector companies, THRD currently prints $-26M for net income, while the sector average sits near $130M. That is roughly 119.7% below the sector mean. Large gaps often invite a closer look at Third Harmonic Bio's growth, margins, and balance sheet.

A net income figure of $-26M for THRD is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $130M. Explore the charts below for those layers of context.

After noting THRD's net income ($-26M), review year-over-year change from $-15M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.